Covid-19 Drugs

German Study Discovers Papaverine’s Potential in Fighting COVID-19 and Calming Immune Reactions

Nikhil Prasad Apr 18, 2025 26 days ago

Medical News: A team of German scientists has uncovered a surprising new use for an old drug. Papaverine, a compound originally used to treat heart and blood vessel conditions, is now showing powerful effects against the SARS-CoV-2 virus. But that is not all — it also helps to calm the body’s immune system, which can sometimes spiral out of control in COVID-19 patients. These findings ...

Drug Resistance Mutations Emerging in SARS-CoV-2 After Ensitrelvir Use in Japan to Treat COVID-19

Nikhil Prasad Feb 18, 2025 3 months ago

Medical News: Researchers Warn of Rising Drug Resistance Mutations in COVID 19 Treatment A new study has raised concerns about emerging drug resistance mutations in patients treated with ensitrelvir, an antiviral drug used to combat COVID-19. Researchers from Kansai Medical University General Medical Center in Osaka and Hokkaido University in Sapporo have identified significant genetic changes in...

U.S FDA Grants Monoclonal Drug Pemgarda Emergency Use Authorization As A COVID-19 Pre-Exposure Prophylaxis For The Immunocompromised

Nikhil Prasad Mar 24, 2024 1 year ago

COVID-19 News: The battle against COVID-19 has been ongoing, and one of the significant challenges has been protecting immunocompromised individuals who are at higher risk of severe outcomes from the virus. In response to this critical need, the U.S. Food and Drug Administration (FDA) recently granted emergency use authorization (EUA) for pemivibart (Pemgarda, Invivyd), a monoclonal antibody, as a...

Anti-Fungal Drug - Ciclopirox Inhibits SARS-CoV-2 By The Degradation Of The Nucleocapsid Protein

Nikhil Prasad Mar 13, 2024 1 year ago

COVID-19 News: The global fight against the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been ongoing for four years, with over 700 million reported cases and 7 million deaths. Despite the development of vaccines and drugs, the rapid mutation of the virus continues to pose a significant public health threat. To address this challeng...

Contrary To Misinformation, Swiss Study Validates That Antidepressants Or SSRIs Do Not Reduce Risk Of SARS-CoV-2 Infection

Nikhil Prasad Mar 13, 2024 1 year ago

COVID-19 News: Antidepressant usage has seen a significant rise in the United Kingdom, with over 100 daily doses prescribed per 1000 inhabitants. Beyond their primary role in addressing depression, antidepressants have been explored for their potential impact on the immune system, particularly through functional inhibition of acid sphingomyelinase (FIASMA). There has been misinformation spread by ...

Carrimycin Inhibits SARS-CoV-2 Replication By Decreasing The Efficiency Of Programmed-1 Ribosomal Frameshifting

Nikhil Prasad Mar 05, 2024 1 year ago

COVID-19 News: The ongoing global battle against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to an urgent quest for effective antiviral treatments. The Chinese Academy of Medical Sciences & Peking Union Medical College has been at the forefront of this research, recently revealing a groundbreaking discovery regarding the antiviral potential of carrimycin. ...

Austrian Scientists Claim That High-Density Lipoproteins Can Be Used As Antivirals Against COVID-19 Infections

Nikhil Prasad Mar 05, 2024 1 year ago

COVID-19 News: The ongoing battle against the global COVID-19 pandemic has led researchers to explore unconventional avenues for therapeutic intervention. In a recent development, scientists at the Medical University of Graz in Austria have unearthed compelling evidence suggesting that High-Density Lipoproteins (HDLs) could serve as potent antivirals against SARS-CoV-2 infections. This COVID-19 Ne...

Clofazimine Identified As A Potential Antiviral Against SARS-CoV-2

Nikhil Prasad Mar 05, 2024 1 year ago

COVID-19 News: In the ongoing battle against the COVID-19 pandemic, the quest for effective antiviral treatments has led researchers to explore the repurposing of existing drugs. Among these, Clofazimine and Arbidol have emerged as promising candidates, demonstrating their efficacy as in vitro SARS-CoV-2 fusion inhibitors. This COVID-19 News report delves into a study conducted at Thomas Jefferson...

Oseltamivir (Tamiflu) Found To Reduce COVID-19 Related In-Hospital Mortality

Nikhil Prasad Feb 13, 2024 1 year ago

COVID-19 News: As the COVID-19 pandemic continues to ravage communities worldwide, the quest for effective treatments remains paramount. Amidst the challenges posed by new variants, limited healthcare resources, and unequal access to medication, repurposing existing drugs has emerged as a promising strategy. One such drug under scrutiny is oseltamivir, commonly known as Tamiflu, traditionally used...

COVID-19 News: SARS-CoV-2 Develops Mutations That Causes Resistance To Any Antivirals Used. In Japan, Use Of Ensitrelvir Resulted In M49L Mutants!

Nikhil Prasad Jan 24, 2024 1 year ago

COVID-19 News: Since the onset of the SARS-CoV-2 pandemic in 2020, the quest for effective antiviral therapies has been a focal point of medical research. As witnessed in previous viral outbreaks, such as Influenza and HIV, the development of potent antiviral treatments plays a pivotal role in managing public health crises. Initial hopes were pinned on the repurposing of broad-spectrum antivirals ...

COVID-19 News: University Of Bristol In Vitro Shows That The HIV Drug Cobicistat Could Be Used As A Broad-Spectrum Antiviral Against All Coronaviruses!

Nikhil Prasad Dec 10, 2023 1 year ago

COVID-19 News: In the relentless battle against global public health threats posed by coronaviruses, a groundbreaking study by the University of Bristol has unveiled a promising contender in the form of an HIV drug called Cobicistat. The research covered in this COVID-19 News report, explores the potential of Cobicistat to serve as a broad-spectrum antiviral, capable of inhibiting various coronavi...

COVID-19 News: Thai Study Shows That Fluvoxamine Does Not Prevent Deterioration In Mild To Moderate COVID-19!

Nikhil Prasad Oct 07, 2023 2 years ago

COVID-19 News: The COVID-19 pandemic has been a global health crisis of unparalleled proportions, leading to immense mortality and morbidity. Initially, the pandemic brought with it a case fatality rate (CFR) of 2.3%. However, as of 2023, this rate has decreased substantially to a range of 0.05%–0.5%, owing to various factors such as vaccination efforts and increased understanding of the dis...

COVID-19 Antivirals: Brazilian Study Reveals Mannose-Binding Lectins As Promising Antiviral Agents Against SARS-CoV-2

Nikhil Prasad Sep 07, 2023 2 years ago

COVID-19 Antivirals: The COVID-19 pandemic has spurred extensive research into the development of effective antiviral treatments to combat the SARS-CoV-2 virus. Among the many avenues explored, an intriguing discovery has emerged from a collaborative effort involving several prestigious Brazilian institutions: the Federal University of Uberlândia (UFU), São Paulo State University (Une...

COVID-19 Drugs: SGLT2 Inhibitors Do Not Improve Survival In Hospitalized COVID-19 Patients, New Study Shows

Nikhil Prasad Aug 31, 2023 2 years ago

COVID-19 Drugs: In the ongoing battle against the COVID-19 pandemic, researchers have been relentlessly searching for treatments that can alleviate the severity of the disease and improve patient outcomes. Sodium glucose co-transporter-2 (SGLT2) inhibitors, known for their cardiovascular and kidney-protective effects in patients with conditions like type 2 diabetes, heart failure, and kidney disea...

BREAKING NEWS! COVID-19 Drugs: Study Finds That Chlorpheniramine Maleate Has Multifaceted Antiviral Properties Against SARS-CoV-2!

Nikhil Prasad Aug 31, 2023 2 years ago

COVID-19 Drugs: In the relentless quest to combat the global scourge of COVID-19, researchers around the world have been fervently exploring existing drugs for their potential antiviral properties. Among the contenders, Chlorpheniramine Maleate (CPM), a first-generation H1 antihistamine, has emerged as a promising candidate in the fight against the Severe Acute Respiratory Syndrome Coronavirus 2 (...

COVID-19 Drugs: Evaluation of Results of Four Phase III Clinical Trials Shows That the HIV Drug Azvudine Is Effective in Treating COVID-19

Thailand Medical News Team Aug 29, 2023 2 years ago

COVID-19 Drugs: In the midst of the global COVID-19 pandemic, researchers and healthcare professionals worldwide have been tirelessly exploring potential treatment options to combat the devastating effects of the virus. One drug that has recently come under the spotlight for its potential efficacy is Azvudine (FNC), originally developed for the treatment of HIV. This synthetic nucleoside analog ha...

COVID-19 News: Chinese Meta Study Uncovers That Thymosin-α-1 Reduces Risk Of Mortality In COVID-19 Patients With Disease Severity

Thailand Medical News Team Aug 26, 2023 2 years ago

COVID-19 News: The global impact of Coronavirus Disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been nothing short of catastrophic. As the world grapples with this ongoing pandemic, researchers and medical professionals continue their relentless pursuit of effective treatments to mitigate the disease's devastating effects. One such treatme...

COVID-19 Drugs: U.S. NIH Murine Study Shows Finds That Endogenous And Therapeutic 25-Hydroxycholesterols Worsens Early SARS-CoV-2 Pathogenesis!

Thailand Medical News Team Aug 25, 2023 2 years ago

COVID-19 Drugs: The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has triggered unprecedented research efforts to understand the virus's behavior and identify potential treatments. Amid this global crisis, the search for therapeutic agents that can combat the virus has led scientists to explore the properties of 25-hydroxycholesterols (25HC), ox...

COVID-19 Drugs: Early Clinical Data Shows That Celecoxib Monotherapy Helps For Treatment Of Moderate Depressive Symptoms Following COVID-19 Infection

Thailand Medical News Team Aug 24, 2023 2 years ago

COVID-19 Drugs: The COVID-19 pandemic has not only challenged the global healthcare system but also revealed a range of unexpected health consequences beyond the acute respiratory symptoms caused by the virus. One of these unforeseen consequences has been the impact on mental health, particularly depressive symptoms experienced by individuals recovering from COVID-19. In light of this, researchers...

BREAKING! University Of Maryland Study Finds That Pyronaridine Tetraphosphate Is An Effective Antiviral Against All Coronaviruses And SARS-CoV-2 Variants!

Thailand Medical News Team Aug 23, 2023 2 years ago

COVID-19 News: The COVID-19 pandemic, stemming from the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), continues to pose a significant threat to global public health. As new variants of the virus emerge, the efficacy of current treatment options is compromised, underscoring the need for effective antiviral and anti-inflammatory therapies. While various compounds have shown promise i...

International COVID-19 Drug Trials Reveal No Clinical Benefit Of Early Enoxaparin Administration For Symptomatic COVID-19 Outpatients

Thailand Medical News Team Aug 19, 2023 2 years ago

COVID-19 Drugs: COVID-19, the viral respiratory infection that has swept the globe, has claimed the lives of over 6.9 million individuals worldwide. As researchers continue to grapple with understanding the multifaceted nature of the disease, a recent international study lead by researchers by the University of Zurich that also involved numerous scientists and institutions from around the world ha...

COVID-19 Drugs: University Of Virginia Mice Study Demonstrates That Adenosine A2AR Agonist - Apadenoson Significantly Improves COVID-19 Survival Rate!

Thailand Medical News Team Aug 19, 2023 2 years ago

COVID-19 Drugs: The ongoing battle against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the COVID-19 pandemic, has driven relentless research to identify effective treatments and interventions. A pivotal COVID-19 Drugs study conducted by the University of Virginia School of Medicine has illuminated a potential breakthrough in the form of the adenos...

Game-Changing Diabetes Drugs Show Remarkable Impact On COVID-19 Survival - Two-Year Observational Study Unveils Potential Lifesaving Benefits

Thailand Medical News Team Aug 19, 2023 2 years ago

COVID-19 Drugs: In a new study conducted by a consortium of esteemed medical institutions including the University of Ferrara-Italy, SS. Annunziata Hospital-Italy, University Hospital of Ferrara Arcispedale Sant’Anna-Italy, and Azienda Unità Sanitaria Locale della Romagna-Italy, the potential life-saving effects of novel antidiabetic drugs, specifically GLP-1 receptor agonists (GLP-1 ...

COVID-19 Drugs: University of Maryland Study Finds That Regadenoson Can Be Used In COVID-19 Treatment As It Produces Rapid Anti-Inflammatory Effects!

Thailand Medical News Team Aug 17, 2023 2 years ago

COVID-19 Drugs: The global pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) led to unprecedented challenges in healthcare systems and research worldwide. As medical professionals tirelessly sought effective treatments for COVID-19, a groundbreaking study conducted at the University of Maryland in the United States offers new hope. The study sheds light on the potent...

University of Arkansas Study Finds That Tocilizumab Increases Risk of Fungal Infections And Acute Renal Failure In Critically Ill COVID-19 Patients!

Thailand Medical News Team Aug 17, 2023 2 years ago

COVID-19 Drugs: In a new study conducted by researchers at the University of Arkansas for Medical Sciences-USA, a concerning link has been identified between the use of the immunomodulatory drug tocilizumab and an increased risk of fungal infections and acute renal failure in critically ill patients battling severe cases of COVID-19. The study sheds light on potential complications associated with...

New Peer Reviewed Study Published In Nature Journal Shows That Hydroxychloroquine Could Be Used As A COVID-19 Prophylactic

Thailand Medical News Team Aug 07, 2023 2 years ago

COVID-19 Drugs: The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has posed a significant global health challenge, with millions of people affected and a high mortality rate. In the quest for effective treatments and prophylactic agents, Hydroxychloroquine (HCQ), an antimalarial drug, emerged as a controversial candidate recommended for prophylactic u...

Drugs That Target the Acid Sphingomyelinase/Ceramide System Found To Reduce 28-Day Mortality Among Adult Patients Hospitalized With COVID-19

Thailand Medical News Aug 06, 2023 2 years ago

COVID-19 Drugs: The COVID-19 pandemic has been a significant global health crisis, challenging healthcare systems and economies worldwide. Despite advancements in vaccination efforts, effective outpatient treatments for COVID-19 remain crucial, especially for low- and middle-income countries. The acid sphingomyelinase (ASM)/ceramide system has emerged as a potential target for treating COVID-19, w...

University Of Michigan Study Finds That Proxalutamide Inhibits Various SARS-CoV-2 Variants And Reduces COVID-19 Associated Inflammatory Response

Thailand Medical News Team Aug 06, 2023 2 years ago

COVID-19 Drugs: The COVID-19 pandemic has wreaked havoc worldwide, prompting scientists and researchers to explore innovative therapeutics to combat the SARS-CoV-2 virus. While vaccines have been claimed to prevent severe disease, the emergence of new variants and breakthrough infections highlight the need for effective antiviral drugs. In this context, the University of Michigan conducted a groun...

COVID-19 Drugs Study FindsThat N-Acetylcysteine Reduces Post-COVID Myocardial Injury And Sulodexide Aids In Endothelial Cells Recovery

COVID-19-Drugs - N-Acetylcysteine - Sulodexide Jul 27, 2023 2 years ago

Study Finds That Both N-Acetylcysteine And Sulodexide Has Protective Properties On Endothelial Cells After SARS-CoV-2 Infection COVID-19 Drugs: The world was taken by storm when the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged, causing the coronavirus disease 2019 (COVID-19) pandemic. Beyond its devastating impact on the respiratory system, this novel virus also wrea...

BREAKING! Cheap Generic Drug Could Be Repurposed As An Effective Prophylactic Against Threat From Emerging SARS-CoV-2 Sublineages And COVID-19 Surges!

COVID-19 Drugs - Prophylactic - Emerging SARS-CoV-2 Sublineages Jul 21, 2023 2 years ago

Thailand Medical News Exclusive: An existing approved generic drug with an already proven safety track record could be used as a prophylactic and also therapeutic drug against SARS-CoV-2. COVID-19 Drugs: While new COVID-19 surges are once again wreaking havoc in countries like Japan, South Korea, parts of Brazil and also China, and also in Australia and New Zealand, COVID-19 cases are also ...

COVID-19 Drugs: Aprotinin - A Promising Drug For Fighting Respiratory Diseases Including Influenza And COVID-19

COVID-19 Drugs – Aprotinin Jul 16, 2023 2 years ago

Aprotinin Might Emerge As An Antiviral Candidate For SARS-CoV-2 And Even Be An Effective Antiviral To Deal With Impending H5N1 Pandemic! COVID-19 Drugs: Respiratory diseases caused by viruses, such as influenza and COVID-19, have been a major global health concern, causing millions of deaths and disrupting daily life. However, there is a potential ray of hope emerging in the form of...

U.S. Study Finds That Suramin Helps Prevent Endotheliopathy. (Relevant In COVID-19 Context)

COVID-19 Drugs - Suramin - COVID-19 - Endotheliopathy Jul 09, 2023 2 years ago

Besides Preventing Endotheliopathy, Suramin Has Also Shown Inhibitory Effects On The Main Protease Required For SARS-CoV-2 Infection COVID-19 Drugs: In a recent study conducted by esteemed institutions including the University of South Florida, University of Vermont, Colorado State University, and University of Wisconsin, researchers have discovered that the drug suramin holds tremendous promise ...

BREAKING NEWS! Metformin Shows Remarkable Results in Reducing SARS-CoV-2 Viral Loads In Phase 3 Randomized Clinical Trial Conducted In America

COVID-19 News - Metformin -Viral Loads - Randomized Clinical Trial Jun 09, 2023 2 years ago

Cheap, Easily Available Generic Diabetic Medication Shows Promising Potential In Treating COVID-19 COVID-19 News: In a groundbreaking development, a Phase 3 randomized placebo-controlled clinical trial has revealed that metformin, a commonly used medication for diabetes, exhibits significant potential in reducing SARS-CoV-2 viral loads. The trial, known as COVID-OUT, involved a collaboratio...

Unveiling New Acyclovir Salts: A Promising Step in COVID-19 Drug Repurposing

COVID-19 Drugs - Acyclovir May 09, 2023 2 years ago

COVID-19 Drugs: Drug repurposing has garnered significant interest as a viable alternative to traditional drug development, offering a cost-effective, time-saving, and less risky approach. Amid the ongoing COVID-19 pandemic, the urgent need for therapeutic agents to prevent viral outbreaks has intensified. Well-established antiviral drugs like acyclovir (Acv) have shown promise in combati...

BREAKING! COVID-19 Drug Strategies Have Been Wrong! SARS-CoV-2 Infections Affects Drug Metabolizing Enzymes And Membrane Transporters In Tissues!

COVID-19 Drugs - Drug Metabolizing Enzymes And Membrane Transporters (DMETs) May 01, 2023 2 years ago

COVID-19 Drugs: It is coming to light that all strategies with regards to treating COVID-19 has been wrong as many missed out certain critical data that affects the pharmacokinetics and pharmacodynamics of these drugs that have been approved so far by various clueless regulatory agencies across the world. A new breakthrough study by researchers from University of Toronto-Canada, OneDrug-C...

COVID-19 Drugs: Spanish Researchers Find That Early Treatment With Antihistamines Like Cetirizine Can Reduce Risk Of COVID-19 Hospitalization!

COVID-19 Drugs - Antihistamines - Cetirizine Apr 26, 2023 2 years ago

COVID-19 Drugs: A groundbreaking study by Spanish researchers from Servicio de Salud de Castilla-La Mancha (SESCAM) in Toledo, Spain, has unveiled the astonishing potential of antihistamines as an early treatment for COVID-19. This discovery could revolutionize our approach to managing the pandemic, reduce hospitalizations, and possibly prevent the spread of the virus among close contacts. ...

COVID-19 News: 5-Aminolevulinic Acid (ALA) Emerging As A Potential Safe And Effective Antiviral Against SARS-CoV-2 Infections

COVID-19 News - 5-Aminolevulinic Acid (ALA) Apr 09, 2023 2 years ago

COVID-19 News: As the world continues to grapple with the COVID-19 pandemic, a natural amino acid, 5-aminolevulinic acid (ALA), is emerging as a potential antiviral for SARS-CoV-2 infections. This groundbreaking discovery could pave the way for an innovative treatment strategy that targets the angiotensin-converting enzyme 2 (ACE2) receptor, which plays a critical role in the virus's ability t...

COVID-19 Drugs: Study Indicates That DHFR Inhibitors Such As Methotrexate, Pralatrexate, Trimetrexate Can Be Repurposed As SARS-CoV-2 Antivirals

COVID-19 Drugs - Methotrexate, Pralatrexate, Trimetrexate Apr 07, 2023 2 years ago

COVID-19 Drugs: Since the outbreak of the COVID-19 pandemic, the scientific community has been tirelessly working to find effective therapeutic strategies to treat SARS-CoV-2-induced respiratory disease. Repurposing approved drugs has emerged as the most rapid, affordable, and efficient strategy for addressing this urgent need. Among the drugs tested for repurposing, methotrexate (MTX), a widely u...

Study Finds SARS-CoV-2 Spike Protein Accumulating In Skull Marrow, Brain Meninges And Brain Parenchyma While Killing Brain Cells!

COVID-19 News - Spike Protein Accumulating In Skull Marrow, Brain Meninges And Brain Parenchyma Apr 06, 2023 2 years ago

COVID-19 News: A new study by German and Danish researchers have found the SARS-Cov-2 spike protein accumulating in skull marrow, brain meninges and brain parenchyma while killing brain cells of those who had been exposed to the spike proteins either by infection or by so called mRNA ‘prophylactics.’ The SARS-CoV-2 virus, responsible for the COVID-19 pandemic, has been associa...

Endogenous piRNAs – The Next Armaments For The Battle With SARS-CoV-2 Omicron Variants And Even Cancer!

COVID-19 News - Endogenous piRNAs Apr 05, 2023 2 years ago

COVID-19 News: In an astounding revelation, a groundbreaking study by researchers from the Polish Academy of Sciences and A. Baitursynov Kostanay Regional University in Kazakhstan has identified a potential game-changer in the battle against the relentless SARS-CoV-2 Omicron variant. Although the research is still in its preliminary, in silico phase, the astonishing findings are impossibl...

COVID-19 News: Scientists Warn SARS-CoV-2 Is Mutating To Escape All Known Clinical Protease Inhibitors. Multi-Drug Approach Recommended

COVID-19 News : Resistance To Clinical Protease Inhibitors Mar 30, 2023 2 years ago

COVID-19 News: Research led by scientist from the University of Minnesota-USA has found that the SARS-CoV-2 coronavirus is evolving to escape all known clinical protease inhibitors. As drug resistance becomes a major issue in the coming CVID-19 onslaughts, a strategy of using a combination of antivirals like that in HIV treatment protocols might be a better solution. The study also compri...

COVID-19 Drugs: Tucaresol Emerging As A Potential COVID-19 Antiviral And Drug To Treat SARS-CoV-2 Induced Lymphopenia And Immunodeficiency

COVID-19 Drugs - Tucaresol Mar 23, 2023 2 years ago

COVID-19 Drugs: Tucaresol, an is an orally administered antisickling agent which increases the oxygen affinity of hemoglobin is emerging as a potential COVID-19 antiviral and drug to treat SARS-CoV-2 induced lymphopenia and immunodeficiency according to researchers from ChemThera Sciences, a pharmaceutical research company based in Montreal, Canada with a branch in Delaware, United States. ...

COVID-19 Drugs: Study Suggest That G4-Binding Drugs, Chlorpromazine And Prochlorperazine Could Be Repurposed Against SARS-CoV-2 Infections

COVID-19 Drugs - Chlorpromazine And Prochlorperazine Mar 21, 2023 2 years ago

COVID-19 Drugs: Indian researchers after conducting successful animal model drug trials involving hamsters are suggesting that G4-binding drugs, chlorpromazine and prochlorperazine could be repurposed against SARS-CoV-2 infections. Chlorpromazine, marketed under the brand names Thorazine and Largactil among others, is an antipsychotic oral medication. It is primarily used to treat psychot...

COVID-19 Drugs: A Potential Breakthrough in COVID-19? The Role of Beta-Amido Boronic Acids in Inhibiting SARS-CoV-2 M(pro)

COVID-19 Drugs - Beta-Amido Boronic Acids Mar 12, 2023 2 years ago

COVID-19 Drugs: The COVID-19 pandemic has been a global health crisis unlike any other in recent memory. It has affected millions of people around the world, and finding a cure has become a top priority for researchers and medical professionals. While vaccines have been developed and distributed, there is still a need for effective treatments for those who have already contracted the virus..hence ...

COVID19-Drugs: Indomethacin In The Treatment Of SARS-CoV-2 Infections: A Promising Option

COVID-19 Drugs - Indomethacin Mar 11, 2023 2 years ago

COVID-19 Drugs: Since the beginning of the COVID-19 pandemic, researchers have been exploring various treatment options to combat the virus. One such option is the use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as indomethacin. While the use of NSAIDs in COVID-19 treatment remains a topic of debate, several studies have suggested that indomethacin, in particular, could be an effective t...

Long COVID News: Study Shows That Maraviroc and Pravastatin Can Be Used To Treat Long COVID

Long COVID News - Maraviroc - Pravastatin Mar 11, 2023 2 years ago

Long COVID News: A study by American and Costa Rican researchers has found that the drugs Maraviroc and Pravastatin can be used to treat Long COVID. Maraviroc, sold under the brand names Selzentry and Celsentri, is an antiretroviral medication used to treat HIV infection. It is taken by mouth. It is in the CCR5 receptor antagonist class. It was approved for medical use in the United State...

Long COVID News: University Of Minnesota Study Shows That Early Use Of Metformin During SARS-CoV-2 Infection Can Prevent Long COVID

Long COVID News - Metformin Prevents Long COVID Mar 10, 2023 2 years ago

Long COVID News: In a recent study, researchers from the University of Minnesota-USA investigated the potential benefits of early outpatient treatment of COVID-19 patients with metformin, ivermectin, or fluvoxamine in preventing the development of Long COVID, also known as post-acute sequelae of COVID-19 (PASC). Their study findings showed that early use of metformin during initial SAR-Co...

COVID-19 News: Harvard Randomized Trial Surprisingly Finds That Untreated COVID-19 Individuals Fair Better Than Those Treated With Paxlovid!

COVID-19 News - Untreated COVID-19 Feb 22, 2023 2 years ago

COVID-19 News: A new study conducted by researchers from Brigham and Women's Hospital, Harvard Medical School,Massachusetts-USA and Harvard T.H. Chan School of Public Health-Massachusetts-USA involving a randomized clinical trial has surprisingly found that untreated COVID-19 infected individuals tend to fair better than those treated with Paxlovid (nirmatrelvir–ritonavir) in terms...

COVID-19 News: Study Finds That Two Cholesterol-Lowering Drugs, Gemfibrozil And Lovastatin, Reduces SARS-CoV-2 Propagation In Brain Cells!

COVID-19 News - Gemfibrozil & Lovastatin, Reduces SARS-CoV-2 Neuroinfection Feb 13, 2023 2 years ago

COVID-19 News: A new study by South Korean researchers from Chonnam National University, Korea Research Institute of Chemical Technology along with scientist from University of North Carolina at Chapel Hill-USA has found that SARS-CoV-2 neuroinvasiveness and neuroinfection is governed by cholesterol homeostasis and translational machinery-associated genes! The study team found that brain corticoge...

COVID-19 News: China Approves Two New Drugs To Treat COVID-19- Xiannuoxin (Simnotrelvir/Ritonavir) and VV116 (Deuremidevir Hydrobromide).

COVID-19 News -China-Anti-SARS-CoV-2 Drugs - Xiannuoxin - VV116 Feb 08, 2023 2 years ago

COVID-19 News: The Chinese Academy of Sciences at Beijing has announced that China's National Medical Products Administration (NMPA) has conditionally approved tow new drugs to treat COVID-19 after an urgent review and approval under the Special Examination and Approval of Drugs Policy. These two new novel antivirals are reported to be effective anti-SARS-CoV-2 drugs are Xiannuoxin (s...

COVID-19 News: Japanese Researchers Warn That The Usage Of Inhaled Ciclesonide In Driving SARS-CoV-2 NSp3 And Nsp4 Mutations!

COVID-19 News- Ciclesonide - Nsp3 - Nsp4 Mutations Feb 01, 2023 2 years ago

COVID-19 News: Researchers from the Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Murayama Branch, Tokyo-Japan have in a new study discovered that the usage of the inhaled asthma drug ciclesonide is causing frequent occurrences of SARS-CoV-2 NSp3 And Nsp4 Mutations! Thailand Medical News had in our previous COVID-19 News coverages s...

BREAKING! COVID-19 Drugs: Columbia Researchers Find That Serotonin And SSRI Drugs Like Fluvoxamine Can Cause Heart Valve Disease!

COVID-19 Drugs - Fluvoxamine Causes Heart Valve Disease Jan 28, 2023 2 years ago

COVID-19 Drugs: Researchers from Columbia University’s Department of Surgery in collaboration with the Pediatric Heart Valve Center at Children’s Hospital of Philadelphia (CHOP), the University of Pennsylvania, and the Valley Hospital Heart Institute have discovered that serotonin can impact the mitral valve of the heart and potentially accelerate a cardiac condition known as degenerat...

BREAKING! COVID-19 Drugs: Study Shows That N-Acetylcysteine or NAC Is An Effective Antiviral And Immunomodulatory Drug Against All SARS-CoV-2 Variants!

COVID-19 Drugs - N-Acetylcysteine or NAC Jan 12, 2023 2 years ago

COVID-19 Drugs: A new study by Italian researchers have found that NAC or N-Acetylcysteine is not only an effective antiviral agent against all of the SARS-CoV-2 variants but also has immunomodulatory properties that can help prevent disease severity. Thailand Medical News had as early as April 2020 written about the benefits of taking NAC or N-Acetylcysteine supplements to help prevent C...

COVID-19 Drugs: University Of Oxford Study Shows That Molnupiravir Does Not Reduce Hospitalization Or Deaths In Vaccinated Adults With COVID-19!

COVID-19 Drugs - Molnupiravir Dec 24, 2022 2 years ago

COVID-19 Drugs: A new study led by researchers from University of Oxford has found that Molnupiravir that is being promoted by many charlatans and dubious health experts and authorities, does not reduce hospitalization or risk of mortality in vaccinated adults who have contracted COVID-19! In fact, the overpriced drug that costs more than US$720 for a seven-day course day course has been ...

COVID-19 News: Cholesterol And Ceramides Facilitate SARS-CoV-2 Spike Protein-Mediated Membrane Fusion Which Can Be Inhibited By Chlorpromazine!

COVID-19 News - Chlorpromazine Dec 17, 2022 2 years ago

COVID-19 News: A new study by researchers from Inserm (French National Institute of Health and Medical Research) has validated that cholesterol and ceramide lipids facilitate SARS-CoV-2 spike protein-mediated membrane fusion. The researchers also found that Chlorpromazine (CPZ), a commonly used antipsychotic drug, could be used to inhibit this fusion and also prevent SARS-CoV-2 cellular e...